These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 36309415)
21. Testosterone treatment for the aging man: the controversy. Morales A Curr Urol Rep; 2004 Dec; 5(6):472-7. PubMed ID: 15541218 [TBL] [Abstract][Full Text] [Related]
22. HIV-associated hypogonadism. Cohan GR AIDS Read; 2006 Jul; 16(7):341-5, 348, 352-4. PubMed ID: 16874913 [TBL] [Abstract][Full Text] [Related]
23. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer? Gould DC; Kirby RS Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770 [TBL] [Abstract][Full Text] [Related]
26. To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer. Kava BR Curr Urol Rep; 2014 Jul; 15(7):422. PubMed ID: 24832199 [TBL] [Abstract][Full Text] [Related]
27. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat. Lazarou S; Morgentaler A Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923 [TBL] [Abstract][Full Text] [Related]
28. Investigating the basis of sexual dysfunction during late-onset hypogonadism. Tharakan T; Miah S; Jayasena C; Minhas S F1000Res; 2019; 8():. PubMed ID: 30984376 [TBL] [Abstract][Full Text] [Related]
30. [Testosterone replacement therapy for hypogonadism in men with prostate cancer]. Jensen CF; Fode M; Østergren P; Sønksen J Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152 [TBL] [Abstract][Full Text] [Related]
31. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma? Landau D; Tsakok T; Aylwin S; Hughes S Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone. Hohl A; Marques MO; Coral MH; Walz R Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):989-95. PubMed ID: 20126852 [TBL] [Abstract][Full Text] [Related]
33. Male hormone replacement therapy including "andropause". Tenover JL Endocrinol Metab Clin North Am; 1998 Dec; 27(4):969-87, x. PubMed ID: 9922917 [TBL] [Abstract][Full Text] [Related]
34. Male hypogonadism: pathogenesis, diagnosis, and management. De Silva NL; Papanikolaou N; Grossmann M; Antonio L; Quinton R; Anawalt BD; Jayasena CN Lancet Diabetes Endocrinol; 2024 Oct; 12(10):761-774. PubMed ID: 39159641 [TBL] [Abstract][Full Text] [Related]
35. [Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth]. Rinnab L; Gust K; Hautmann RE; Küfer R Urologe A; 2009 May; 48(5):516-22. PubMed ID: 19296069 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone. Chrysant SG; Chrysant GS Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348 [TBL] [Abstract][Full Text] [Related]
38. Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism. Santella C; Renoux C; Yin H; Yu OHY; Azoulay L Am J Epidemiol; 2019 Sep; 188(9):1666-1673. PubMed ID: 31145457 [TBL] [Abstract][Full Text] [Related]
39. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237 [TBL] [Abstract][Full Text] [Related]
40. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis]. Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]